NELTEO Trademark

Trademark Overview

On Wednesday, February 20, 2013, a trademark application was filed for NELTEO with the United States Patent and Trademark Office. The USPTO has given the NELTEO trademark a serial number of 85854615. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 17, 2016. This trademark is owned by Millennium Pharmaceuticals, Inc.. The NELTEO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use, namely, for the treatment of hematological malignancies, cancer, auto-immune diseases and disorders and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of cancer
nelteo

General Information

Serial Number85854615
Word MarkNELTEO
Filing DateWednesday, February 20, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 17, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 16, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use, namely, for the treatment of hematological malignancies, cancer, auto-immune diseases and disorders and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 27, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMillennium Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameMillennium Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Monday, October 17, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 17, 2016ABANDONMENT - NO USE STATEMENT FILED
Saturday, February 20, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 19, 2016EXTENSION 5 GRANTED
Thursday, February 18, 2016EXTENSION 5 FILED
Thursday, February 18, 2016TEAS EXTENSION RECEIVED
Tuesday, August 18, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 17, 2015EXTENSION 4 GRANTED
Monday, August 10, 2015EXTENSION 4 FILED
Monday, August 10, 2015TEAS EXTENSION RECEIVED
Friday, February 27, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 26, 2015EXTENSION 3 GRANTED
Tuesday, February 17, 2015EXTENSION 3 FILED
Tuesday, February 17, 2015TEAS EXTENSION RECEIVED
Thursday, September 4, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 3, 2014EXTENSION 2 GRANTED
Monday, August 11, 2014EXTENSION 2 FILED
Wednesday, September 3, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 11, 2014TEAS EXTENSION RECEIVED
Wednesday, March 5, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 3, 2014EXTENSION 1 GRANTED
Monday, March 3, 2014EXTENSION 1 FILED
Monday, March 3, 2014TEAS EXTENSION RECEIVED
Monday, March 3, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 10, 2013NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 16, 2013PUBLISHED FOR OPPOSITION
Wednesday, June 26, 2013NOTICE OF PUBLICATION
Monday, June 10, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 5, 2013ASSIGNED TO EXAMINER
Wednesday, February 27, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Sunday, February 24, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

nelteo diseases pharmaceutical cancer treatment disorders preparations inflammatory immune malignancies human